Correction: Thy1 Nk Cells from Vaccinia Virus-Primed Mice Confer Protection against Vaccinia Virus Challenge in the Absence of Adaptive Lymphocytes.

Correction: Thy1 Nk Cells from Vaccinia Virus-Primed Mice Confer Protection against Vaccinia Virus Challenge in the Absence of Adaptive Lymphocytes.

Bibliographic Details
Main Authors:	Geoffrey O. Gillard, Maytal Bivas-Benita, Avi-Hai Hovav, Lauren E. Grandpre, Michael W. Panas, Michael S. Seaman, Barton F. Haynes, Norman L. Letvin
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2011-08-01
Series:	PLoS Pathogens
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160455/?tool=EBI

Similar Items

Thy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes.
by: Geoffrey O Gillard, et al.
Published: (2011-08-01)

Vaccinia Virus in Household Environment during Bovine Vaccinia Outbreak, Brazil
by: Felipe L. Assis, et al.
Published: (2013-12-01)

Enhancing the Immunogenicity of Vaccinia Virus
by: Sergei N. Shchelkunov, et al.
Published: (2022-06-01)

Brazilian Vaccinia Viruses and Their Origins
by: Giliane S. Trindade, et al.
Published: (2007-07-01)

Vaccinia virus and poxvirology : methods and protocols /
by: Isaacs, Stuart Neal
Published: (2004)

Oncolytic vaccinia virus and cancer immunotherapy
by: Lihua Xu, et al.
Published: (2024-01-01)

Immunotherapeutic Potential of Oncolytic Vaccinia Virus
by: Stephen eThorne
Published: (2014-06-01)

Theranostic Potential of Oncolytic Vaccinia Virus
by: Juan J Rojas, Steve H Thorne
Published: (2012-01-01)

Experimental infection of horses with Vaccinia virus
by: Claudio Henrique Gonçalves Barbosa, et al.
Published: (2015-01-01)

Group 2 Vaccinia Virus, Brazil
by: Felipe Lopes Assis, et al.
Published: (2012-12-01)

Passatempo Virus, a Vaccinia Virus Strain, Brazil
by: Juliana A. Leite, et al.
Published: (2005-12-01)

Educational Approach to Prevent the Burden of Vaccinia Virus Infections in a Bovine Vaccinia Endemic Area in Brazil
by: Galileu Barbosa Costa, et al.
Published: (2021-04-01)

Protection of Mice from Lethal Vaccinia Virus Infection by Vaccinia Virus Protein Subunits with a CpG Adjuvant
by: Sarah Reeman, et al.
Published: (2017-12-01)

Vaccinia Virus Arrests and Shifts the Cell Cycle
by: Caroline K. Martin, et al.
Published: (2022-02-01)

Oncolytic Vaccinia Virus in Lung Cancer Vaccines
by: Cao-Sang Truong, et al.
Published: (2022-02-01)

Functional epitopes and neutralizing antibodies of vaccinia virus
by: Fenghao Peng, et al.
Published: (2023-10-01)

Genetic ancestry and population structure of vaccinia virus
by: Cristian Molteni, et al.
Published: (2022-08-01)

Vaccinia Virus Infection in Monkeys, Brazilian Amazon
by: Jônatas S. Abrahão, et al.
Published: (2010-06-01)

Live-Cell Imaging of Vaccinia Virus Recombination.
by: Patrick Paszkowski, et al.
Published: (2016-08-01)

Isolation and characterization of cidofovir resistant vaccinia viruses
by: Prichard Mark N, et al.
Published: (2008-05-01)

Immunodomination during peripheral vaccinia virus infection.
by: Leon C W Lin, et al.
Published: (2013-01-01)

Development of the drug oncolytic immunotherapy based on vaccinia viruses <i>(Vaccinia virus, Orthopoxvirus, Chordopoxvirinae, Poxviridae)</i> against breast cancer
by: T. V. Bauer, et al.
Published: (2020-02-01)

A new inhibitor of apoptosis from vaccinia virus and eukaryotes.
by: Caroline Gubser, et al.
Published: (2007-02-01)

Characterisation of an Anti-Vaccinia Virus F13 Single Chain Fragment Variable from a Human Anti-Vaccinia Virus-Specific Recombinant Immunoglobulin Library
by: Henrike P. Ahsendorf, et al.
Published: (2022-01-01)

Clinical development of Modified Vaccinia virus Ankara vaccines
by: Gilbert, S
Published: (2013)

Clinical development of Modified Vaccinia virus Ankara vaccines.
by: Gilbert, S
Published: (2013)

Vaccinia virus utilizes microtubules for movement to the cell surface.
by: Hollinshead, M, et al.
Published: (2001)

Investigation of strategies to enhance the delivery of oncolytic vaccinia virus
by: Hill, C
Published: (2020)

Recent progress in combination therapy of oncolytic vaccinia virus
by: Seyedeh Nasim Mirbahari, et al.
Published: (2024-03-01)

A Cancer-Favoring, Engineered Vaccinia Virus for Cholangiocarcinoma
by: So Young Yoo, et al.
Published: (2019-10-01)

Rapid detection of anti-Vaccinia virus neutralizing antibodies
by: Lichtfuss Gregor F, et al.
Published: (2011-03-01)

Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory
by: Jonas D. Albarnaz, et al.
Published: (2018-02-01)

Functional characterization of the vaccinia virus I5 protein
by: Stanitsa Eleni S, et al.
Published: (2008-12-01)

Features of the Antitumor Effect of Vaccinia Virus Lister Strain
by: Evgeniy Zonov, et al.
Published: (2016-01-01)

Pathogeneses of respiratory infections with virulent and attenuated vaccinia viruses
by: Terajima Masanori, et al.
Published: (2007-02-01)

A succession of two viral lattices drives vaccinia virus assembly.
by: Miguel Hernandez-Gonzalez, et al.
Published: (2023-03-01)

A mechanism for induction of a hypoxic response by vaccinia virus.
by: Mazzon, M, et al.
Published: (2013)

A new inhibitor of apoptosis from vaccinia virus and eukaryotes.
by: Gubser, C, et al.
Published: (2007)

Polymeric cups for cavitation mediated delivery of oncolytic vaccinia virus
by: Myers, R, et al.
Published: (2016)

Design Strategies and Precautions for Using Vaccinia Virus in Tumor Virotherapy
by: Xinjun Liu, et al.
Published: (2022-09-01)